| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Business Operations: The Chicken Before The Egg |
|
Just Other Articles - Business Operations: The Chicken Before The Egg
There are a few businesses that do not have a need for managing their business operations. And they are just a f According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ew. So few, I can not think of a business that does not have some sort activity they do in business that could n ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ot be considered their business operation. Something as given as making a bank run or going to the office supply lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. store or having new business cards and contracts made up, all could be considered business operations. If one o here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe f these activities was not done or done correctly how would it affect the business? However, most businesses ope d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rations are much more complex. Especially where there are employees involved. Even then there should be a sepa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ration of operations and the human resources. What is taken place today is more businesses are trying to do more easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi with less. Business owners, in hopes of saving a buck, are doing away with operations managers and taking upon nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically themselves to do the work of a COO. I consider and coach my clients that if there is a need to cut budget while and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ evaluating strategies, to make the cut on the front end, not where the quality is produced. One of the biggest m ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi stakes made by business executives and owners is to take for granted the management of their operations. Too man ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a y business people put far too much emphasis on marketing and sales when operations need to play an equal or great dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod er role. Over the years I have sat in many meetings where the conversation come down to the ‘Chicken or the Egg’ cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin theories. The sales groups claim that if it was not for their efforts to bring in the revenue there would not b tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e a reason to generate a product. While operations saying that if there was not for them producing a quality pr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel oduct to show the client there would not be any sales made to generate any revenue. And this debate still goes o ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n today. Who wins? Well, as unpopular as it is for the high strung sales people to take, it is not sales that c y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products omes first. Since the Chicken is the operation that produces the egg, you have to take care of the Chicken to in . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de sure there is a quality product. Once there is a product then it should be simple for sales to sale it, but not elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip before then. Yes, business’ operations has to be established before a business knows what it is they are selling tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Save Time Writing Branded Materials With A Content Blocks Document How to Get the Courage to Pursue Your Dream Career
|